| |
|
|
|
Matinas BioPharma Holdings- Inc.  
|
|
0.5001 -0.05 (-0.09%) |
06-19 16:00 |
|
Open: |
0.51 |
Pre close: |
0.5504 |
Target:
|
0.67
|
|
High: |
0.5822 |
Low: |
0.5 |
Resistance:
|
0.58
0.66
|
|
Volume: |
533,416 |
Market Cap: |
47M |
Support:
|
0.44
0.37
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.54
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.56 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.77 |
Stochastic Oscillator |
%K(14,3):
|
53.93  |
|
MA(250): |
1.11 |
%D(3): |
49.25 |
|
Average Volume(K) |
3-Month: |
32850
|
52-Week |
High:
|
2.79 |
|
10-Days: |
52175 |
Low: |
0.43 |
|
RSI |
RSI(14):
|
44.38 |
Change(%): |
-81.5 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-177.8 |
Shares Out. (M) |
94.04 |
|
EPS Est. Current Year |
-0.290 |
Return on Assets (ttm) |
-84.9 |
Shares Float (M) |
81.09 |
|
EPS Est. Next Year |
-0.240 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.050 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
11.00 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1725 |
|
Book Value (p.s.) |
15.610 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.03 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-11.46 |
P/S |
0.00 |
|
Operating Margin |
-11024.61 |
Levered Free Cash Flow
(M) |
-7.04 |
P/CF |
-4.10 |
|
|
|
|
|
|
